Skip to content
2000
Volume 22, Issue 14
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

UDP-glucose is an essential metabolite for a variety of processes in the cell physiology in all organisms. In prokaryotes, it is involved in the synthesis of trehalose, an osmoprotectant, in galactose utilization via the Leloir pathway and it plays a key role in the synthesis of the components of the bacterial envelope, particularly the lipopolysaccharide and the capsule, which represent necessary virulence factors of many bacterial pathogens. UDP-glucose is synthesized in bacteria by the prokaryotic UDP-glucose pyrophosphorylase (UGP, EC 2.7.7.9), an enzyme belonging to the family of sugar:nucleotidyl transferases. Despite the ubiquitous distribution of UGP activity in all domains of life, prokaryotic UGPs are evolutionarily unrelated to their eukaryotic counterparts. Taken together, these features make of bacterial UGP an attractive target candidate for the discovery and development of new generation antibiotics. This review summarizes the current knowledge on structure and function of bacterial UGPs, underlying their potential as drug target candidates.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867322666150114151248
2015-05-01
2025-09-02
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867322666150114151248
Loading

  • Article Type:
    Research Article
Keyword(s): Antibiotic; drug discovery; drug target; GalU; glycobiology; glycosyltransferase; UGP
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test